Advancing synergistic combination medicines, non-opioid solutions for chronic pain, neuropsychiatric disorders, and substance use disorders using patient-friendly delivery methods. AUSTIN, Texas, May 05, 2026 (GLOBE NEWSWIRE) — EPIK Biosciences (“EPIK” or the... 